Subscribe To
Opko health to present new clinical data on rayaldee (er calcifediol) at kidney week 2023
MIAMI, Oct. 25, 2023 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) will present late-breaking clinical data on RAYALDEE® extended-release calc...
October 25, 2023, 8:25 pm
Opko health to present new clinical data on rayaldee (er calcifediol) at kidney week 2023
MIAMI, Oct. 25, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) will present late-breaking clinical data on RAYALDEE® extended-release calci...
October 25, 2023, 4:25 pm
Calliditas therapeutics to present seven abstracts at the american society of nephrology (asn) kidney week 2023
STOCKHOLM , Oct. 19, 2023 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX) ("Calliditas"), today announced seven ab...
October 19, 2023, 3:58 am
Travere therapeutics to present abstracts at the american society of nephrology (asn) kidney week 2023
Two late-breaking high-impact oral presentations of the Phase 3 PROTECT Study of FILSPARI® (sparsentan) in IgAN and Phase 3 DUPLEX Study of sparsenta...
October 13, 2023, 8:30 pm
Travere therapeutics to present abstracts at the american society of nephrology (asn) kidney week 2023
Two late-breaking high-impact oral presentations of the Phase 3 PROTECT Study of FILSPARI ® (sparsentan) in IgAN and Phase 3 DUPLEX Study of sparsent...
October 13, 2023, 4:30 pm
Vera therapeutics to present three posters at the american society of nephrology kidney week 2023 annual meeting
Informational poster for ORIGIN 3 Pivotal Phase 3 study evaluating atacicept in IgA Nephropathy (IgAN) Additional analysis of week 36 data from Phase ...
October 13, 2023, 2:22 pm
Eledon pharmaceuticals to present data from ongoing phase 1b trial of tegoprubart in patients undergoing kidney transplantation at the american society of nephrology kidney week 2023 annual meeting
IRVINE, Calif., Oct. 13, 2023 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that the Company will pr...
October 13, 2023, 11:00 am
Vera therapeutics to present three posters at the american society of nephrology kidney week 2023 annual meeting
Informational poster for ORIGIN 3 Pivotal Phase 3 study evaluating atacicept in IgA Nephropathy (IgAN) Additional analysis of week 36 data from Phase ...
October 13, 2023, 10:22 am
Alpine immune sciences to present initial clinical data on povetacicept in autoimmune glomerulonephritis in a late breaker poster session at american society of nephrology kidney week 2023
SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative...
October 13, 2023, 9:05 am
Ardelyx to present data updates for xphozah (tenapanor) for hyperphosphatemia at kidney week 2023 november 1-5 in philadelphia, pa
WALTHAM, Mass., Oct. 13, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develo...
October 13, 2023, 8:00 am
Zyversa therapeutics announces peer-reviewed publication in nature reviews nephrology substantiating var 200’s rationale for mediating transport of cholesterol and lipids out of kidney cells to attenu
This review paper summarizes numerous research studies that address the role of kidney cholesterol and lipid accumulation in the development and progr...
October 11, 2023, 11:05 am
Zyversa therapeutics announces peer-reviewed publication in nature reviews nephrology substantiating var 200’s rationale for mediating transport of cholesterol and lipids out of kidney cells to attenu
This review paper summarizes numerous research studies that address the role of kidney cholesterol and lipid accumulation in the development and progr...
October 11, 2023, 11:05 am
Alpine immune sciences: november 2023 data release could get ball rolling
Preliminary clinical data from the Alpine Immune Sciences, Inc. ongoing phase 3 RUBY-3 study will be presented at the American Society of ...
October 6, 2023, 3:31 pm
Gic, tpg healthcare fund buys major stake in indian hospital chain for $72 mln
Specialty investment firm Asia Healthcare Holdings, backed by U.S. private equity investor TPG and Singapore sovereign fund GIC, has acquired a major ...
September 20, 2023, 5:47 am
Adtalem (atge) & davita to launch nephrology nursing course
Adtalem (ATGE) collaborates with DaVita to prepare nursing students for nephrology careers....
September 13, 2023, 3:02 pm
Interventional radiology products market size worth usd 42 billion by 2032 at 5.80% cagr – report by market research future (mrfr)
Interventional Radiology Products Market Trends and Insights By Type (Stents, Catheters, Inferior Vena Cava (IVC) Filters, Embolization Devices, Throm...
June 15, 2023, 2:45 pm
Travere therapeutics announces interim analysis from the phase 3 protect study of filspari™ (sparsentan) in iga nephropathy published in the lancet and presented at world congress of nephrology 2023
FILSPARI demonstrated a statistically significant, rapid, and sustained decline of proteinuria compared to the active control SAN DIEGO, April 01, 202...
April 1, 2023, 8:30 am
Eledon reports data from ongoing phase 1b trial evaluating tegoprubart in patients undergoing kidney transplantation at world congress of nephrology
Results from three participants demonstrated no incidence of acute rejection at durations of 56, 154, and 232 days Strong graft function observed in a...
March 31, 2023, 10:00 am
Alpine immune sciences to present povetacicept (alpn-303) phase 1 (ruby-1) study data and clinical pharmacokinetic & pharmacodynamic modeling at upcoming scientific conferences
SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative...
March 20, 2023, 4:30 pm
Davita clinical research to present new findings at american society of nephrology kidney week 2021
DENVER, Nov. 4, 2021 /PRNewswire/ -- DaVita Clinical Research (DCR) will present eight research abstracts from company representatives and medical pr...
November 4, 2021, 6:04 am